Development of a novel class of tumor-selective CYP1A1-activated chloromethylindolines

被引：0
|
作者：
Pors, Klaus
Sheldrake, Helen
Shnyder, Steve
Sutherland, Mark
Loadman, Paul
Gordon, Andrew
Searcey, Mark
Patterson, Laurence
机构：
[1] Univ Bradford, Bradford BD7 1DP, W Yorkshire, England
[2] Univ East Anglia, Norwich NR4 7TJ, Norfolk, England
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
673
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Tumor-selective sensitization of NSCLC to TRAIL by Mdivi-1
    Suzuki, Yoshihiro
    LUNG CANCER, 2012, 77 : S17 - S17
  • [2] Human CYP1A1-activated aneugenicity of aflatoxin B1 in mammalian cells and its combined effect with benzo(a)pyrene
    Wang, Huanhuan
    Fan, Qin
    Liang, Qian
    Wu, Yao
    Ye, Zhongming
    Wu, Haipeng
    Sun, Qian
    Tang, Huanwen
    Liu, Yungang
    Liu, Qizhan
    Chen, Yuting
    CHEMICO-BIOLOGICAL INTERACTIONS, 2024, 392
  • [3] The ERK/MAPK scaffold IQGAP1 is a tumor-selective target
    Jameson, Katherine L.
    Zehnder, Ashley M.
    Khavari, Paul A.
    CANCER RESEARCH, 2011, 71
  • [4] Synthesis and biological evaluation of a tumor-selective degrader of PARP1
    Pu, Chunlan
    Wang, Shirui
    Luo, Dan
    Liu, Yuanyuan
    Ma, Xinyu
    Zhang, Hongjia
    Yu, Su
    Lan, Suke
    Huang, Qing
    Deng, Rui
    He, Xiang
    Li, Rui
    BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 69
  • [5] Development of a Tumor-Selective Approach to Treat Metastatic Cancer
    Aboody, Karen S.
    Bush, Rebecca A.
    Garcia, Elizabeth
    Metz, Marianne Z.
    Najbauer, Joseph
    Justus, Kristine A.
    Phelps, Doris A.
    Remack, Joanna S.
    Yoon, Karina Jin
    Gillespie, Shanna
    Kim, Seung U.
    Glackin, Carlotta A.
    Potter, Philip M.
    Danks, Mary K.
    PLOS ONE, 2006, 1 (01):
  • [6] Impact of E1 a modifications on tumor-selective adenoviral replication and toxicity
    Sauthoff, H
    Pipiya, T
    Heitner, S
    Chen, S
    Bleck, B
    Reibman, J
    Chang, W
    Norman, RG
    Rom, WN
    Hay, JG
    MOLECULAR THERAPY, 2004, 10 (04) : 749 - 757
  • [7] Synthesis of tumor-associated glycopeptide antigens for the development of tumor-selective vaccines
    Dziadek, S
    Kunz, H
    CHEMICAL RECORD, 2004, 3 (06): : 308 - 321
  • [8] Prodrugs of the cytostatic CC-1065 that can be activated in a tumor-selective manner
    Tietze, LF
    Hannemann, R
    Buhr, W
    Logers, M
    Menningen, P
    Lieb, M
    Starck, D
    Grote, T
    Doring, A
    Schubert, I
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1996, 35 (22): : 2674 - 2677
  • [9] Type 1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles Virus
    Aref, Sarah
    Castleton, Anna Z.
    Bailey, Katharine
    Burt, Richard
    Dey, Aditi
    Leongamornlert, Daniel
    Mitchell, Rachel J.
    Okasha, Dina
    Fielding, Adele K.
    MOLECULAR THERAPY, 2020, 28 (04) : 1043 - 1055
  • [10] NQO1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck Cancer
    Li, Long-Shan
    Reddy, Srilakshmi
    Lin, Zhen-Hua
    Liu, Shuangping
    Park, Hyunsil
    Chun, Stephen G.
    Bornmann, William G.
    Thibodeaux, Joel
    Yan, Jingsheng
    Chakrabarti, Gaurab
    Xie, Xian-Jin
    Sumer, Baran D.
    Boothman, David A.
    Yordy, John S.
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (07) : 1757 - 1767
12345